Pharma and tech giants are pouring hundreds of millions into diabetes technology, designing gadgets and developing software aimed at helping patients manage a burdensome disease.
They’re chasing what could be a blockbuster market: Close to 30 million Americans have diabetes and can face health problems including dangerously low blood sugar, vision loss, and kidney damage.
